Notice of Availability of Environmental Assessment and Finding of No Significant Impact for License Amendment for Pharmacopeia, Incorporated's Facility in Monmouth Junction, NJ, 3567-3568 [05-1282]

Download as PDF Federal Register / Vol. 70, No. 15 / Tuesday, January 25, 2005 / Notices and (6) of section 552b of title 5, United States Code. 1. Date: February 1, 2005. Time: 8:30 a.m.–5 p.m. Room: 415. Program: This meeting will review applications for History, submitted to the Office of Challenge Grants at the November 1, 2004 deadline. 2. Date: February 1, 2005. Time: 8:30 a.m.–5:30 p.m. Room: 415. Program: This meeting will review applications for Humanities Projects in Media, submitted to the Division of Public Programs at the November 3, 2004 deadline. 3. Date: February 2, 2005. Time: 9 a.m. to 5 p.m. Room: 315. Program: This meeting will review applications for Collaborative Research in European Studies, submitted to the Division of Research Programs at the November 1, 2004 deadline. 4. Date: February 3, 2005. Time: 8:30 a.m. to 5 p.m. Room: 415. Program: This meeting will review applications for Colleges and Universities I, submitted to the Office of Challenge Grants at the November 1, 2004 deadline. 5. Date: February 4, 2005. Time: 9 a.m. to 5 p.m. Room: 315. Program: This meeting will review applications for Collaborative Research in Literature and the Arts, submitted to the Division of Research Programs at the November 1, 2004 deadline. 6. Date: February 7, 2005. Time: 9 a.m. to 5 p.m. Room: 315. Program: This meeting will review applications for Collaborative Research in Africa and Asia, submitted to the Division of Research Programs at the November 1, 2004 deadline. 7. Date: February 8, 2005. Time: 8:30 a.m. 5 p.m. Room: 415. Program: This meeting will review applications for Art and Anthropology, submitted to the Office of Challenge Grants at the November 1, 2004 deadline. 8. Date: February 9, 2005. Time: 9 a.m. to 5 p.m. Room: 315. Program: This meeting will review applications for Scholarly Editions in American History, submitted to the Division of Research Programs at the November 1, 2004 deadline. 9. Date: February 10, 2005. Time: 9 a.m. to 5 p.m. VerDate jul<14>2003 13:14 Jan 24, 2005 Jkt 205001 Room: 315. Program: This meeting will review applications for Collaborative Research in Philosophy, Science, and Religion, submitted to the Division of Research Programs at the November 1, 2004 deadline. 10. Date: February 10, 2005. Time: 8:30 a.m. 5 p.m. Room: 415. Program: This meeting will review applications for Colleges and Universities II, submitted to the Office of Challenge Grants at the November 1, 2004 deadline. 11. Date: February 11, 2005. Time: 9 a.m. 5 p.m. Room: 315. Program: This meeting will review applications for Collaborative Research in American Studies, submitted to the Division of Research Programs at the November 1, 2004 deadline. Daniel Schneider, Advisory Committee Management Officer. [FR Doc. 05–1313 Filed 1–24–05; 8:45 am] BILLING CODE 7536–01–P NUCLEAR REGULATORY COMMISSION [Docket No. 030–33542] Notice of Availability of Environmental Assessment and Finding of No Significant Impact for License Amendment for Pharmacopeia, Incorporated’s Facility in Monmouth Junction, NJ Nuclear Regulatory Commission. ACTION: Notice of availability. AGENCY: FOR FURTHER INFORMATION CONTACT: John I. Introduction The Nuclear Regulatory Commission (NRC) is issuing a license amendment to Pharmacopeia, Inc. for Materials License No. 29–30152–01, to authorize release of its facility in Monmouth Junction, New Jersey for unrestricted use. NRC has prepared an Environmental Assessment (EA) in support of this action in accordance with the requirements of 10 CFR part 51. Based on the EA, the NRC has concluded that a Finding of No Significant Impact (FONSI) is appropriate. The amendment will be Frm 00061 Fmt 4703 Sfmt 4703 issued following the publication of this Notice. II. EA Summary The purpose of the action is to authorize the release of the licensee’s Monmouth Junction, New Jersey facility for unrestricted use. Pharmacopeia, Inc. was authorized by NRC from February 1999 to use radioactive materials for research and development purposes at the site. On April 28, 2004, Pharmacopeia, Inc. requested that NRC release the facility for unrestricted use. Pharmacopeia, Inc. has conducted surveys of the facility and provided information to the NRC to demonstrate that the site meets the license termination criteria in Subpart E of 10 CFR part 20 for unrestricted use. Pharmacopeia, Inc. will continue licensed activities at another location, as authorized by the license. The NRC staff has prepared an EA in support of the license amendment. The facility was remediated and surveyed prior to the licensee requesting the license amendment. The NRC staff has reviewed the information and final status survey submitted by Pharmacopeia, Inc. Based on its review, the staff has determined that there are no additional remediation activities necessary to complete the proposed action. Therefore, the staff considered the impact of the residual radioactivity at the facility and concluded that since the residual radioactivity meets the requirements in Subpart E of 10 CFR Part 20, a Finding of No Significant Impact is appropriate. III. Finding of No Significant Impact Nicholson, Commercial and R&D Branch, Division of Nuclear Materials Safety, Region I, 475 Allendale Road, King of Prussia, Pennsylvania, 19406, telephone (610) 337–5236, fax (610) 337–5269; or by email: jjn@nrc.gov. SUPPLEMENTARY INFORMATION: PO 00000 3567 The staff has prepared the EA (summarized above) in support of the license amendment to release the facility for unrestricted use. The NRC staff has evaluated Pharmacopeia, Inc.’’s request and the results of the surveys and has concluded that the completed action complies with the criteria in Subpart E of 10 CFR Part 20. The staff has found that the environmental impacts from the action are bounded by the impacts evaluated by NUREG–1496, Volumes 1–3, ‘‘Generic Environmental Impact Statement in Support of Rulemaking on Radiological Criteria for License Termination of NRC-Licensed Facilities’ (ML042310492, ML042320379, and ML042330385). On the basis of the EA, the NRC has concluded that the environmental impacts from the action are expected to be insignificant and has determined not to prepare an environmental impact statement for the action. E:\FR\FM\25JAN1.SGM 25JAN1 3568 Federal Register / Vol. 70, No. 15 / Tuesday, January 25, 2005 / Notices IV. Further Information ACTION: Documents related to this action, including the application for the license amendment and supporting documentation, are available electronically at the NRC’s Electronic Reading Room at https://www.nrc.gov/ reading-rm/adams.html. From this site, you can access the NRC’s Agencywide Document Access and Management System (ADAMS), which provides text and image files of NRC’s public documents. The ADAMS accession numbers for the documents related to this Notice are: The Environmental Assessment (ML043340345), Letter dated April 28, 2004, requesting the amendment (ML041330096), Letter dated September 14, 2004, providing additional information (ML042720160), and Letter from New Jersey Department of Environmental Protection dated November 15, 2004 (ML043290297). Please note that on October 25, 2004, the NRC terminated public access to ADAMS and initiated an additional security review of publicly available documents to ensure that potentially sensitive information is removed from the ADAMS database accessible through the NRC’s web site. Interested members of the public may obtain copies of the referenced documents for review and/or copying by contacting the Public document Room pending resumption of public access to ADAMS. The NRC Public documents Room is located at NRC Headquarters in Rockville, MD, and can be contacted at (800) 397–4209 or (301) 415–4737, or by email to pdr@nrc.gov. The PDR reproduction contractor will copy documents for a fee. The PDR is open from 7:45 a.m. to 4:15 p.m., Monday through Friday, except on Federal holidays. Dated at King of Prussia, Pennsylvania, this 14 day of January, 2005. For the Nuclear Regulatory Commission. James Dwyer, Chief, Commercial and R&D Branch, Division of Nuclear Materials Safety Region I. [FR Doc. 05–1282 Filed 1–24–05; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [Docket No. 40–8027] Notice of Availability of Environmental Assessment and Finding of No Significant Impact for License Amendment for Sequoyah Fuels Corporation, Gore, OK Nuclear Regulatory Commission. AGENCY: VerDate jul<14>2003 13:14 Jan 24, 2005 Jkt 205001 Notice of availability. FOR FURTHER INFORMATION CONTACT: Myron Fliegel, Project manager, Fuel Cycle Facilities Branch, Division of Fuel Cycle Safety and Safeguards, Office of Nuclear Material Safety and Safeguards, U.S. Nuclear Regulatory Commission, Washington, DC, 20555. Telephone: (301) 415–6629; fax number: (301) 415– 5955; e-mail: mhf1@nrc.gov. SUPPLEMENTARY INFORMATION: I. Introduction The Nuclear Regulatory Commission (NRC) is issuing a license amendment to Material License No. SUB–1010 issued to Sequoyah Fuels Corporation (the licensee), to authorize the licensee to dewater existing raffinate sludge and temporarily store the dewatered sludge at its Gore, Oklahoma facility prior to final disposition. NRC has prepared an Environmental Assessment (EA) in support of this amendment in accordance with the requirements of 10 CFR Part 51. Based on the EA, the NRC has concluded that a Finding of No Significant Impact (FONSI) is appropriate. The amendment will be issued following the publication of this Notice. II. EA Summary The purpose of the proposed amendment is to authorize the licensee to dewater existing raffinate sludge and temporarily store the dewatered sludge at its Gore, Oklahoma facility prior to final disposition. Approximately 1 million cubic feet of raffinate sludge was produced, as a waste, during the operation of the SFC facility. The sludge, which contains various metals in addition to uranium, thorium, and radium, is 15 to 20 percent solid material and is stored in three hypalonlined impoundments on the site. It must be dewatered prior to permanent disposal, either in an onsite disposal cell or offsite at a licensed disposal facility. The licensee proposes to dewater the raffinate sludge using a pressurized plate press filtering process. The equipment would be set up in an area near the impoundments containing the sludge and dismantled at the conclusion of the dewatering process. The dewatered sludge would be put into 2200 pound capacity bags of woven polypropylene fabric and temporarily stored on a nearby concrete pad prior to final disposal. Temporary storage cells will be constructed on the concrete pad to contain the bags of raffinate sludge. The cells will be lined with 20 mil, high density cross-laminated polyethylene and covered with the same material. PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 On January 7, 2004, Sequoyah Fuels Corporation requested that NRC approve the proposed amendment. The licensee’s request for the proposed change was previously noticed in the Federal Register on March 17, 2004 (69 FR 12715), with a notice of an opportunity to request a hearing. The staff has prepared the EA in support of the proposed license amendment. The only environmental impact under normal conditions would be an increase in the radon concentration in the air at the site. However, the radon concentration at the site boundary would be well below the 10 CFR Part 20 standard. There is also a potential for release of some material during adverse meteorological conditions. In the unlikely event of a tornado strike on the cells, some of the sludge can be dispersed, but it is unlikely that it would be carried offsite. The licensee would be required to clean up the dispersed material. Some severe precipitation events could result in release of some sludge to the nearby Illinois River and Robert S. Kerr Reservoir but concentrations are unlikely to exceed the standards for normal releases in 10 CFR Part 20. The staff has concluded that the proposed action, to dewater existing raffinate sludge and temporarily store it in lined and covered cells, will result in minimal environmental impacts. Radon levels will be increased but will remain well within regulatory limits. In addition, there is the potential, under unusual conditions (e.g., during a severe storm), of releasing small amounts of contaminants in low concentrations, to the Robert S. Kerr Reservoir. III. Finding of No Significant Impact On the basis of the EA, NRC has concluded that there are no significant environmental impacts from the proposed amendment and has determined not to prepare an environmental impact statement. IV. Further Information Documents related to this action, including the application for amendment and supporting documentation, are available electronically at the NRC’s Electronic Reading Room at https://www.nrc.gov/ reading-rm/adams.html. From this site, you can access the NRC’s Agencywide Document Access and Management System (ADAMS), which provides text and image files of NRC’s public documents. The ADAMS accession numbers for the documents related to this notice are: SFC’s amendment request, January 7, 2004, ML040150463 and NRC’s Environmental Assessment, E:\FR\FM\25JAN1.SGM 25JAN1

Agencies

[Federal Register Volume 70, Number 15 (Tuesday, January 25, 2005)]
[Notices]
[Pages 3567-3568]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-1282]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Docket No. 030-33542]


Notice of Availability of Environmental Assessment and Finding of 
No Significant Impact for License Amendment for Pharmacopeia, 
Incorporated's Facility in Monmouth Junction, NJ

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of availability.

-----------------------------------------------------------------------

FOR FURTHER INFORMATION CONTACT: John Nicholson, Commercial and R&D 
Branch, Division of Nuclear Materials Safety, Region I, 475 Allendale 
Road, King of Prussia, Pennsylvania, 19406, telephone (610) 337-5236, 
fax (610) 337-5269; or by email: jjn@nrc.gov.

SUPPLEMENTARY INFORMATION:

I. Introduction

    The Nuclear Regulatory Commission (NRC) is issuing a license 
amendment to Pharmacopeia, Inc. for Materials License No. 29-30152-01, 
to authorize release of its facility in Monmouth Junction, New Jersey 
for unrestricted use. NRC has prepared an Environmental Assessment (EA) 
in support of this action in accordance with the requirements of 10 CFR 
part 51. Based on the EA, the NRC has concluded that a Finding of No 
Significant Impact (FONSI) is appropriate. The amendment will be issued 
following the publication of this Notice.

II. EA Summary

    The purpose of the action is to authorize the release of the 
licensee's Monmouth Junction, New Jersey facility for unrestricted use. 
Pharmacopeia, Inc. was authorized by NRC from February 1999 to use 
radioactive materials for research and development purposes at the 
site. On April 28, 2004, Pharmacopeia, Inc. requested that NRC release 
the facility for unrestricted use. Pharmacopeia, Inc. has conducted 
surveys of the facility and provided information to the NRC to 
demonstrate that the site meets the license termination criteria in 
Subpart E of 10 CFR part 20 for unrestricted use. Pharmacopeia, Inc. 
will continue licensed activities at another location, as authorized by 
the license.
    The NRC staff has prepared an EA in support of the license 
amendment. The facility was remediated and surveyed prior to the 
licensee requesting the license amendment. The NRC staff has reviewed 
the information and final status survey submitted by Pharmacopeia, Inc. 
Based on its review, the staff has determined that there are no 
additional remediation activities necessary to complete the proposed 
action. Therefore, the staff considered the impact of the residual 
radioactivity at the facility and concluded that since the residual 
radioactivity meets the requirements in Subpart E of 10 CFR Part 20, a 
Finding of No Significant Impact is appropriate.

III. Finding of No Significant Impact

    The staff has prepared the EA (summarized above) in support of the 
license amendment to release the facility for unrestricted use. The NRC 
staff has evaluated Pharmacopeia, Inc.''s request and the results of 
the surveys and has concluded that the completed action complies with 
the criteria in Subpart E of 10 CFR Part 20. The staff has found that 
the environmental impacts from the action are bounded by the impacts 
evaluated by NUREG-1496, Volumes 1-3, ``Generic Environmental Impact 
Statement in Support of Rulemaking on Radiological Criteria for License 
Termination of NRC-Licensed Facilities' (ML042310492, ML042320379, and 
ML042330385). On the basis of the EA, the NRC has concluded that the 
environmental impacts from the action are expected to be insignificant 
and has determined not to prepare an environmental impact statement for 
the action.

[[Page 3568]]

IV. Further Information

    Documents related to this action, including the application for the 
license amendment and supporting documentation, are available 
electronically at the NRC's Electronic Reading Room at https://
www.nrc.gov/reading-rm/adams.html. From this site, you can access the 
NRC's Agencywide Document Access and Management System (ADAMS), which 
provides text and image files of NRC's public documents. The ADAMS 
accession numbers for the documents related to this Notice are: The 
Environmental Assessment (ML043340345), Letter dated April 28, 2004, 
requesting the amendment (ML041330096), Letter dated September 14, 
2004, providing additional information (ML042720160), and Letter from 
New Jersey Department of Environmental Protection dated November 15, 
2004 (ML043290297). Please note that on October 25, 2004, the NRC 
terminated public access to ADAMS and initiated an additional security 
review of publicly available documents to ensure that potentially 
sensitive information is removed from the ADAMS database accessible 
through the NRC's web site. Interested members of the public may obtain 
copies of the referenced documents for review and/or copying by 
contacting the Public document Room pending resumption of public access 
to ADAMS. The NRC Public documents Room is located at NRC Headquarters 
in Rockville, MD, and can be contacted at (800) 397-4209 or (301) 415-
4737, or by email to pdr@nrc.gov. The PDR reproduction contractor will 
copy documents for a fee. The PDR is open from 7:45 a.m. to 4:15 p.m., 
Monday through Friday, except on Federal holidays.

    Dated at King of Prussia, Pennsylvania, this 14 day of January, 
2005.

    For the Nuclear Regulatory Commission.
James Dwyer,
Chief, Commercial and R&D Branch, Division of Nuclear Materials Safety 
Region I.
[FR Doc. 05-1282 Filed 1-24-05; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.